Therapeutic Nuclear Medicines Market
Market Insights on Therapeutic Nuclear Medicines covering sales outlook, demand forecast & up-to-date key trends
Therapeutic Nuclear Medicines Market By Treatment (Radium-223, Iodine-131, Leutitium-177, Yttrium-90, Samarium-153, Strontium-89, Rhenium-188+Rhenium-186, Erbium- 169, Phosphorous-32), Indication (Prostate Cancer, Painful Bone Metastases, Thyroid Cancer, Neuroblastoma, Synovitis, Non-Hodgkin's Lymphoma, Hepatic Metastases, Brain Tumour) & Region - Forecast 2022 - 2028
Therapeutic Nuclear Medicines Market Outlook (2022-2028)
[237 Pages Report] Expanding at a CAGR of 10.6%, the global therapeutic nuclear medicines market is projected to increase from a valuation of US$ 1 Bn in 2022 to US$ 1.84 Bn by 2028.
|
Therapeutic Nuclear Medicines Market Size (2022) |
US$ 1 Bn |
|
Sales Forecast (2028) |
US$ 1.84 Bn |
|
Global Market Growth Rate (2022 to 2028) |
10.6% CAGR |
|
Share of Top 5 Market Players |
60% |
Therapeutic nuclear medicine consumption accounted for 18.1% share of the global nuclear medicine market in 2021.
Let us know your requirement to get
100% FREE customization
Consumption Analysis of Therapeutic Nuclear Medicines (2013-2021) Vs Market Outlook (2022 to 2028)
“Growing Need for Early & Reliable Diagnosis – Need of the Hour”
From 2013 to 2021, the global therapeutic nuclear medicines market registered significant gains, experiencing a CAGR of 9.2%
A pharmaceutical composition including radioactive elements is known as therapeutic nuclear medicine. In comparison to X-rays and other external radiation imaging technologies, therapeutic nuclear medicines are widely employed as an effective and safer alternative for cancer patients. Chemotherapy is being mainly supplanted by nuclear medications for cancer treatment as a result of this.
Nuclear medicine is widely utilized for the early diagnosis and treatment of a variety of chronic disorders. Nuclear medicine is consumed, injected, or inhaled, depending on the technique. These drugs are becoming increasingly important for delivering imaging and data on biochemical changes, which was previously difficult to access.
To reproduce internal images, these drugs move through the body as gamma rays, which must be intercepted by computers and sophisticated cameras. The therapeutic nuclear medicines industry is predicted to grow due to an increase in chronic diseases and increased knowledge of nuclear medicine.
Considering these factors, the market is projected to witness high growth over the forecast period, registering a CAGR of 10.6% to reach US$ 1.84 Bn by 2028.
What are the Main Drivers of the Therapeutic Nuclear Medicines Market?
“Increasing Acceptance of Radiopharmaceuticals for Therapeutic Purposes”
The therapeutic nuclear medicines industry is growing owing to the incidence rates of cancer and cardiac illnesses, as well as attempts to address the supply gap for Mo-99 and radiopharmaceuticals. Thyroid issues, lung ailments, bone diseases, and brain disorders like neuroblastoma are some of the conditions for which studies and research are conducted.
For oncology and cancer treatment, traditional chemotherapy techniques are being substituted by more efficient therapeutic radiopharmaceuticals that bring new paths in the radiopharmaceuticals industry. With the introduction of radiotheranostics, which integrates treatment with radioisotopes and targeted diagnosis to provide an alternative in the treatment of many cancers, the market has changed dramatically in recent years.
Radiotheranostics is focused on the use of radio-isotopes that generate radiation that can be used to specifically eliminate cancer cells. Furthermore, when compared to X-Rays and other external radiation imaging devices, it not only supports physicians in diagnosis but also serves as an efficient and secure option for patients.
In applications like lymphoma and bone metastasis, radiopharmaceuticals, also generally recognized as nuclear medicines, are used. Globally, leading pharmaceutical companies are increasingly focusing on developing important drugs that are innovative. In addition, the market for nuclear medicines is likely to play a significant part in this development.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhich Factors are Hampering Sales of Therapeutic Nuclear Medicines?
“High Cost of Nuclear Medicine Development Relative to RoI Hampering Market Growth”
Therapeutic nuclear medicines market expansion is likely to be hampered by stringent regulatory requirements and a lack of standardized resources in several developed and emerging nations. High costs, a paucity of isotopes, and the potential of conventional diagnostic testing are all impeding the demand for nuclear medicines.
Because of the radioactivity of these drugs, they can only be used in certain circumstances, such as pregnancy and in modest doses. Radiation and chemical breakdown occurs when radioisotopes are not used within the designated shelf life, reducing radiochemical purity to an extreme amount, which can be lethal during diagnostic and therapy.
Why is North America Expected to Lead the Global Therapeutic Nuclear Medicines Market?
“Growing Adoption of Nuclear Medicine Procedures as Better Medical Solutions”
Substantial market growth in North America can be linked to the development of nuclear medicine procedures, government support, increased R&D expenditure, and industry activities.
Due to supply stabilization and rising instances of chronic diseases such as cancers, the market in North America is predicted to rise rapidly. In addition, pharmaceutical industry development is on the rise.
Growing innovation, as well as faster and simpler FDA approvals, are projected to propel the therapeutic nuclear pharmaceuticals industry forward.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Country-wise Analysis
What is the Outlook for the U.S. Therapeutic Nuclear Medicines Market?
“Rising Incidence of Prostate Cancer Fueling Consumption of Diagnostic Nuclear Medicines”
Prevalence of prostate cancer is rising throughout the globe, especially in the U.S. which is fueling the demand for diagnostic nuclear medicines.
According to the American Cancer Society, prostate cancer is the most common cause of death in the U.S. around 1 in 9 men are expected to be diagnosed with prostate cancer during their lifetime.
Therefore, increase in the incidence of prostate cancer is expected to drive usage of therapeutic nuclear medicines over the forecast period.
How Lucrative is the Market for Therapeutic Nuclear Medicines in China?
“Innovation in Pharmaceutical Industry Driving Demand for Therapeutic Drugs”
China is the most lucrative market for therapeutic nuclear medicines uptake, owing to the growing cancer patient pool and a continually rising rate of radiopharmaceuticals prescription in the country.
Furthermore, a number of pharmaceutical and medical businesses in China are concentrating on the development of therapeutic drugs for the diagnosis and treatment of a variety of ailments, paving the way for market growth.
Category-wise Insights
Which Treatment Accounts for Highest Revenue Generation?
“Expansion of Nuclear Imaging to Boost Demand for Samarium-153”
In the past few years, more efficient therapeutic nuclear medicines have been launched, which have shown positive for the treatment of various types of cancer. Samarium-153 (SM-153) is a beta-emitting drug with the extra advantage of detectable gamma emission for external imaging. The drug has been approved for use in individuals with osteoblastic metastases that can be seen on a nuclear medicine bone scan.
Several breakthroughs in Samarium-153 beta emitters would add to the segment's growth. QSAM Biosciences recently received FDA approval for Samarium-153 DOTMP, an experimental radiopharmaceutical for the treatment of bone cancer.
In addition, the launch of these products has boosted the demand for therapeutic nuclear medicines among patients and physicians as well as opened the door for other pharmaceutical manufacturers to launch more efficient therapeutic nuclear medicines.
Which Distribution Channel Will Emerge as Key Market Contributor?
“Rapid Deployment of Efficient Nuclear Medicine Therapies at Hospitals”
Hospitals are expected to account 37.3% share of the therapeutic nuclear medicines market in 2022. On the basis of the distribution channel, the global market is segmented into hospitals, ambulatory surgical centers, and cancer research institutes.
Because of the huge volume of nuclear imaging treatments performed at these institutions and the increased performance of handling these sensitive items at these sites, the hospitals segment is expected to keep a significant position.
Moreover, leading radiopharmaceutical manufacturers are collaborating with hospitals for the sale of their products, which has increased the acceptance of therapeutic nuclear medicines.
COVID-19 Impact on Therapeutic Nuclear Medicine Demand
As a result of the COVID-19 pandemic, which has resulted in lockdowns in multiple countries throughout the world, the research, production, and distribution of therapeutic nuclear medications were significantly impacted, as was the expansion of various companies' radiopharmaceutical industries.
Lockdowns led to the closure of all industrial institutions, with the exception of those that manufacture vital commodities, as well as a disruption in the supply chain for radiopharmaceuticals and diagnostic and therapeutic kits.
Recent technological developments in nuclear imaging modalities as well as the introduction of innovative pharmaceuticals into the global market have given the industry a huge boost. Continued and persistent R&D activities that result in advancements in new application areas are driving market expansion.
Competitive Landscape
Organic marketing techniques such as mergers and acquisitions, collaborations, and product launches are being used by market vendors to acquire a competitive advantage in the market. Top players produce the majority of nuclear medicine treatments products. Industry leaders have built their position in the market by investing more in research and having a better distribution system.
For instance,
- In 2021, IBA established a strategic R&D agreement with SCK CEN to enable the manufacturing of Actinium-225, a new radioisotope. The substance is claimed to be able to help in cancer treatment.
Therapeutic Nuclear Medicines Industry Report Scope
|
Attribute |
Details |
|
Forecast Period |
2022-2028 |
|
Historical Data Available for |
2013-2021 |
|
Market Analysis |
Value in US$ Mn |
|
Key Regions Covered |
|
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Profiled |
|
|
Pricing |
Available upon Request |
Key Segments of Therapeutic Nuclear Medicines Industry Survey
Therapeutic Nuclear Medicines Market by Treatment:
- Radium-223
- Iodine-131
- Leutitium-177
- Yttrium-90
- Samarium-153
- Strontium-89
- Rhenium-188+Rhenium-186
- Erbium- 169
- Phosphorous-32
- Others
Therapeutic Nuclear Medicines Market by Indication:
- Prostate Cancer
- Painful Bone Metastases
- Thyroid Cancer
- Neuroblastoma
- Synovitis
- Non-Hodgkin’s Lymphoma
- Hepatic Metastases
- Brain Tumour
- Others
Therapeutic Nuclear Medicines Market by Distribution Channel:
- Hospitals
- Ambulatory Surgical Centers
- Cancer Research Institutes
Therapeutic Nuclear Medicines Market by Region:
- North America Therapeutic Nuclear Medicines Market
- Latin America Therapeutic Nuclear Medicines Market
- Europe Therapeutic Nuclear Medicines Market
- East Asia Therapeutic Nuclear Medicines Market
- South Asia & Pacific Therapeutic Nuclear Medicines Market
- Middle East & Africa (MEA) Therapeutic Nuclear Medicines Market
Frequently Asked Questions
The global therapeutic nuclear medicines market is expected to reach US$ 1 Bn in 2022.
Increasing number of cancer cases and rising awareness about nuclear medicine are factors driving market growth.
Hospitals account for 37.3% share of the therapeutic nuclear medicines market.
Key manufacturers of therapeutic nuclear medicines are, Bayer AG, GE Healthcare, Novartis AG, Cardinal Health Inc., and Mallinckrodt plc.
The therapeutic nuclear medicines market is set to surge at a CAGR of 10.6% over the forecast period (2022-2028).
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
2.3. Exclusion and Inclusion
3. Global Economic Outlook
3.1. Gross Domestic Product by Country, 2006 - 2021
3.2. Global Pharmaceutical Market Overview
4. Market Opportunity Analysis
4.1. Macro-Economic Factors
4.2. Opportunity Analysis
5. Market Dynamics
5.1. Drivers
5.1.1. Supply Side Drivers
5.1.2. Demand Side Drivers
5.2. Restraints
5.3. Trends
6. Key Inclusion
6.1. Parent Market Analysis
6.2. Key Regulation
6.3. Reimbursement Scenario
6.4. Pipeline Assessment
6.5. Disease Epidemiology
7. North America Therapeutic Nuclear Medicine Market Analysis 2013-2021 and Forecast 2022-2028
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021
7.2.1. U.S.
7.2.2. Canada
7.3. Market Size (US$ Mn) Forecast By Country, 2022-2028
7.4. Historical Market Size (US$ Mn) Trend Analysis By Radionuclide Type, 2013-2021
7.4.1. Radium-223
7.4.2. Iodine-131
7.4.3. Leutitium-177
7.4.4. Yttrium-90
7.4.5. Samarium-153
7.4.6. Strontium-89
7.4.7. Rhenium-188 + Rhenium-186
7.4.8. Erbium-169
7.4.9. Phosphorus-32
7.4.10. Others
7.5. Market Size (US$ Mn) Forecast By Radionuclide Type, 2022-2028
7.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021
7.6.1. Prostate Cancer
7.6.2. Painful Bone Metastases
7.6.3. Thyroid Cancer
7.6.4. Neuroblastoma
7.6.5. Synovitis
7.6.6. Non-Hodgkins Lymphoma
7.6.7. Hepatic Metastases
7.6.8. Brain Tumour
7.6.9. Others
7.7. Market Size (US$ Mn) Forecast By Indication, 2022-2028
7.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021
7.8.1. Hospitals
7.8.2. Ambulatory Surgical Centers
7.8.3. Cancer Research Institutes
7.9. Market Size (US$ Mn) Forecast By End User, 2022-2028
7.10. Market Attractiveness Analysis
7.10.1. By Radionuclide Type
7.10.2. By Indication
7.10.3. By End User
7.10.4. By Country
7.11. Drivers and Restraints: Impact Analysis
8. Latin America Therapeutic Nuclear Medicine Market Analysis 2013-2021 and Forecast 2022-2028
8.1. Introduction
8.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Argentina
8.2.4. Rest of Latin America
8.3. Market Size (US$ Mn) Forecast By Country, 2022-2028
8.4. Historical Market Size (US$ Mn) Trend Analysis By Radionuclide Type, 2013-2021
8.4.1. Radium-223
8.4.2. Iodine-131
8.4.3. Leutitium-177
8.4.4. Yttrium-90
8.4.5. Samarium-153
8.4.6. Strontium-89
8.4.7. Rhenium-188 + Rhenium-186
8.4.8. Erbium-169
8.4.9. Phosphorus-32
8.4.10. Others
8.5. Market Size (US$ Mn) Forecast By Radionuclide Type, 2022-2028
8.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021
8.6.1. Prostate Cancer
8.6.2. Painful Bone Metastases
8.6.3. Thyroid Cancer
8.6.4. Neuroblastoma
8.6.5. Synovitis
8.6.6. Non-Hodgkins Lymphoma
8.6.7. Hepatic Metastases
8.6.8. Brain Tumour
8.6.9. Others
8.7. Market Size (US$ Mn) Forecast By Indication, 2022-2028
8.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021
8.8.1. Hospitals
8.8.2. Ambulatory Surgical Centers
8.8.3. Cancer Research Institutes
8.9. Market Size (US$ Mn) Forecast By End User, 2022-2028
8.10. Market Attractiveness Analysis
8.10.1. By Radionuclide Type
8.10.2. By Indication
8.10.3. By End User
8.10.4. By Country
8.11. Drivers and Restraints: Impact Analysis
9. Western Europe Therapeutic Nuclear Medicine Market Analysis 2013-2021 and Forecast 2022-2028
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021
9.2.1. Germany
9.2.2. U.K
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Western Europe
9.3. Market Size (US$ Mn) Forecast By Country, 2022-2028
9.4. Historical Market Size (US$ Mn) Trend Analysis By Radionuclide Type, 2013-2021
9.4.1. Radium-223
9.4.2. Iodine-131
9.4.3. Leutitium-177
9.4.4. Yttrium-90
9.4.5. Samarium-153
9.4.6. Strontium-89
9.4.7. Rhenium-188 + Rhenium-186
9.4.8. Erbium-169
9.4.9. Phosphorus-32
9.4.10. Others
9.5. Market Size (US$ Mn) Forecast By Radionuclide Type, 2022-2028
9.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021
9.6.1. Prostate Cancer
9.6.2. Painful Bone Metastases
9.6.3. Thyroid Cancer
9.6.4. Neuroblastoma
9.6.5. Synovitis
9.6.6. Non-Hodgkins Lymphoma
9.6.7. Hepatic Metastases
9.6.8. Brain Tumour
9.6.9. Others
9.7. Market Size (US$ Mn) Forecast By Indication, 2022-2028
9.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021
9.8.1. Hospitals
9.8.2. Ambulatory Surgical Centers
9.8.3. Cancer Research Institutes
9.9. Market Size (US$ Mn) Forecast By End User, 2022-2028
9.10. Market Attractiveness Analysis
9.10.1. By Radionuclide Type
9.10.2. By Indication
9.10.3. By End User
9.10.4. BY Country
9.11. Drivers and Restraints: Impact Analysis
10. Eastern Europe Therapeutic Nuclear Medicine Market Analysis 2013-2021 and Forecast 2022-2028
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021
10.2.1. Russia
10.2.2. Poland
10.2.3. Rest of Eastern Europe
10.3. Market Size (US$ Mn) Forecast By Country, 2022-2028
10.4. Historical Market Size (US$ Mn) Trend Analysis By Radionuclide Type, 2013-2021
10.4.1. Radium-223
10.4.2. Iodine-131
10.4.3. Leutitium-177
10.4.4. Yttrium-90
10.4.5. Samarium-153
10.4.6. Strontium-89
10.4.7. Rhenium-188 + Rhenium-186
10.4.8. Erbium-169
10.4.9. Phosphorus-32
10.4.10. Others
10.5. Market Size (US$ Mn) Forecast By Radionuclide Type, 2022-2028
10.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021
10.6.1. Prostate Cancer
10.6.2. Painful Bone Metastases
10.6.3. Thyroid Cancer
10.6.4. Neuroblastoma
10.6.5. Synovitis
10.6.6. Non-Hodgkins Lymphoma
10.6.7. Hepatic Metastases
10.6.8. Brain Tumour
10.6.9. Others
10.7. Market Size (US$ Mn) Forecast By Indication, 2022-2028
10.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021
10.8.1. Hospitals
10.8.2. Ambulatory Surgical Centers
10.8.3. Cancer Research Institutes
10.9. Market Size (US$ Mn) Forecast By End User, 2022-2028
10.10. Market Attractiveness Analysis
10.10.1. By Radionuclide Type
10.10.2. By Indication
10.10.3. By End User
10.10.4. By Country
10.11. Drivers and Restraints: Impact Analysis
11. APECJ Therapeutic Nuclear Medicine Market Analysis 2013-2021 and Forecast 2022-2028
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021
11.2.1. India
11.2.2. Australia and New Zealand
11.2.3. ASEAN
11.2.4. Rest of APECJ
11.3. Market Size (US$ Mn) Forecast By Country, 2022-2028
11.4. Historical Market Size (US$ Mn) Trend Analysis By Radionuclide Type, 2013-2021
11.4.1. Radium-223
11.4.2. Iodine-131
11.4.3. Leutitium-177
11.4.4. Yttrium-90
11.4.5. Samarium-153
11.4.6. Strontium-89
11.4.7. Rhenium-188 + Rhenium-186
11.4.8. Erbium-169
11.4.9. Phosphorus-32
11.4.10. Others
11.5. Market Size (US$ Mn) Forecast By Radionuclide Type, 2022-2028
11.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021
11.6.1. Prostate Cancer
11.6.2. Painful Bone Metastases
11.6.3. Thyroid Cancer
11.6.4. Neuroblastoma
11.6.5. Synovitis
11.6.6. Non-Hodgkins Lymphoma
11.6.7. Hepatic Metastases
11.6.8. Brain Tumour
11.6.9. Others
11.7. Market Size (US$ Mn) Forecast By Indication, 2022-2028
11.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021
11.8.1. Hospitals
11.8.2. Ambulatory Surgical Centers
11.8.3. Cancer Research Institutes
11.9. Market Size (US$ Mn) Forecast By End User, 2022-2028
11.10. Market Attractiveness Analysis
11.10.1. By Radionuclide Type
11.10.2. By Indication
11.10.3. By End User
11.10.4. By Country
11.11. Drivers and Restraints: Impact Analysis
12. China Therapeutic Nuclear Medicine Market Analysis 2013-2021 and Forecast 2022-2028
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Radionuclide Type, 2013-2021
12.2.1. Radium-223
12.2.2. Iodine-131
12.2.3. Leutitium-177
12.2.4. Yttrium-90
12.2.5. Samarium-153
12.2.6. Strontium-89
12.2.7. Rhenium-188 + Rhenium-186
12.2.8. Erbium-169
12.2.9. Phosphorus-32
12.2.10. Others
12.3. Market Size (US$ Mn) Forecast By Radionuclide Type, 2022-2028
12.4. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021
12.4.1. Prostate Cancer
12.4.2. Painful Bone Metastases
12.4.3. Thyroid Cancer
12.4.4. Neuroblastoma
12.4.5. Synovitis
12.4.6. Non-Hodgkins Lymphoma
12.4.7. Hepatic Metastases
12.4.8. Brain Tumour
12.4.9. Others
12.5. Market Size (US$ Mn) Forecast By Indication, 2022-2028
12.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021
12.6.1. Hospitals
12.6.2. Ambulatory Surgical Centers
12.6.3. Cancer Research Institutes
12.7. Market Size (US$ Mn) Forecast By End User, 2022-2028
12.8. Market Attractiveness Analysis
12.8.1. By Radionuclide Type
12.8.2. By Indication
12.8.3. By End User
12.9. Drivers and Restraints: Impact Analysis
13. Japan Therapeutic Nuclear Medicine Market Analysis 2013-2021 and Forecast 2022-2028
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Radionuclide Type, 2013-2021
13.2.1. Radium-223
13.2.2. Iodine-131
13.2.3. Leutitium-177
13.2.4. Yttrium-90
13.2.5. Samarium-153
13.2.6. Strontium-89
13.2.7. Rhenium-188 + Rhenium-186
13.2.8. Erbium-169
13.2.9. Phosphorus-32
13.2.10. Others
13.3. Market Size (US$ Mn) Forecast By Radionuclide Type, 2022-2028
13.4. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021
13.4.1. Prostate Cancer
13.4.2. Painful Bone Metastases
13.4.3. Thyroid Cancer
13.4.4. Neuroblastoma
13.4.5. Synovitis
13.4.6. Non-Hodgkins Lymphoma
13.4.7. Hepatic Metastases
13.4.8. Brain Tumour
13.4.9. Others
13.5. Market Size (US$ Mn) Forecast By Indication, 2022-2028
13.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021
13.6.1. Hospitals
13.6.2. Ambulatory Surgical Centers
13.6.3. Cancer Research Institutes
13.7. Market Size (US$ Mn) Forecast By End User, 2022-2028
13.8. Market Attractiveness Analysis
13.8.1. By Radionuclide Type
13.8.2. By Indication
13.8.3. By End User
13.9. Drivers and Restraints: Impact Analysis
14. MEA Therapeutic Nuclear Medicine Market Analysis 2013-2021 and Forecast 2022-2028
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021
14.2.1. GCC Countries
14.2.2. South Africa
14.2.3. Rest of Middle East and Africa
14.3. Market Size (US$ Mn) Forecast By Country, 2022-2028
14.4. Historical Market Size (US$ Mn) Trend Analysis By Radionuclide Type, 2013-2021
14.4.1. Radium-223
14.4.2. Iodine-131
14.4.3. Leutitium-177
14.4.4. Yttrium-90
14.4.5. Samarium-153
14.4.6. Strontium-89
14.4.7. Rhenium-188 + Rhenium-186
14.4.8. Erbium-169
14.4.9. Phosphorus-32
14.4.10. Others
14.5. Market Size (US$ Mn) Forecast By Radionuclide Type, 2022-2028
14.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021
14.6.1. Prostate Cancer
14.6.2. Painful Bone Metastases
14.6.3. Thyroid Cancer
14.6.4. Neuroblastoma
14.6.5. Synovitis
14.6.6. Non-Hodgkins Lymphoma
14.6.7. Hepatic Metastases
14.6.8. Brain Tumour
14.6.9. Others
14.7. Market Size (US$ Mn) Forecast By Indication, 2022-2028
14.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021
14.8.1. Hospitals
14.8.2. Ambulatory Surgical Centers
14.8.3. Cancer Research Institutes
14.9. Market Size (US$ Mn) Forecast By End User, 2022-2028
14.10. Market Attractiveness Analysis
14.10.1. By Radionuclide Type
14.10.2. By Indication
14.10.3. By End User
14.10.4. By Country
14.11. Drivers and Restraints: Impact Analysis
15. Forecast Factors: Relevance and Impact
16. Market Structure Analysis
16.1. Market Structure by Tier
16.2. Market Share Analysis (2021) for Top Players, By Region
17. Competition Analysis
17.1. Competition Dashboard
17.2. Competitors Deep Dive
17.2.1. Bayer AG
17.2.2. Novartis AG
17.2.3. GE Healthcare
17.2.4. Curium Pharmaceuticals
17.2.5. Jubilant DraxImage
17.2.6. Spectrum Pharmaceuticals
17.2.7. Progenics Pharmaceuticals, Inc.
17.2.8. ANSTO
17.2.9. Lantheus Medical Imaging, Inc.
17.2.10. Eckert & Ziegler
17.2.11. International Isotopes Inc.
17.2.12. SHINE Medical Technologies Inc.
18. Global Therapeutic Nuclear Medicine Market Analysis 2013-2021 and Forecast 2022-2028 By Country
18.1. Introduction / Key Findings
18.2. Historical Market Size (US$ Mn) Analysis By Country
18.2.1. North America
18.2.2. Latin America
18.2.3. Western Europe
18.2.4. Eastern Europe
18.2.5. Asia Pacific Excluding Japan And China
18.2.6. China
18.2.7. Japan
18.2.8. Middle East and Africa
18.3. Market Size (US$ Mn) Forecast By Country
18.4. Market Attractiveness Analysis By Country
19. Global Therapeutic Nuclear Medicine Market Analysis 2013-2021 and Forecast 2022-2028, By Radionuclide Type
19.1. Introduction/Key Finding
19.2. Historical Market Size (US$ Mn) Analysis By Radionuclide Type, 2013-2021
19.2.1. Radium-223
19.2.2. Iodine-131
19.2.3. Leutitium-177
19.2.4. Yttrium-90
19.2.5. Samarium-153
19.2.6. Strontium-89
19.2.7. Rhenium-188 + Rhenium-186
19.2.8. Erbium-169
19.2.9. Phosphorus-32
19.2.10. Others
19.3. Market Size (US$ Mn) Forecast By Radionuclide Type, 2022-2028
19.4. Market Attractiveness Analysis By Radionuclide Type
20. Global Therapeutic Nuclear Medicine Market Analysis 2013-2021 and Forecast 2022-2028, By Indication
20.1. Introduction/Key Finding
20.2. Historical Market Size (US$ Mn) Analysis By Indication, 2013-2021
20.2.1. Prostate Cancer
20.2.2. Painful Bone Metastases
20.2.3. Thyroid Cancer
20.2.4. Neuroblastoma
20.2.5. Synovitis
20.2.6. Non-Hodgkins Lymphoma
20.2.7. Hepatic Metastases
20.2.8. Brain Tumour
20.2.9. Others
20.3. Market Size (US$ Mn) Forecast By Indication, 2022-2028
20.4. Market Attractiveness Analysis By Indication
21. Global Therapeutic Nuclear Medicine Market Analysis 2013-2021 and Forecast 2022-2028, By End User
21.1. Introduction/Key Finding
21.2. Historical Market Size (US$ Mn) Analysis By End User, 2013-2021
21.2.1. Hospitals
21.2.2. Ambulatory Surgical Centers
21.2.3. Cancer Research Institutes
21.3. Market Size (US$ Mn) Forecast By End User, 2022-2028
21.4. Market Attractiveness Analysis By End User
22. Global Therapeutic Nuclear Medicine Market Analysis 2013-2021 and Forecast 2022-2028
22.1. Global Market Value Analysis (US$ Mn)
22.2. Absolute $ Opportunity (US$ Mn)
23. Assumptions and Acronyms Used
24. Research Methodology
Let us know your requirement to get
100% FREE customization
- Expenditure on Health, (% of GDP), by Country, 2016 – 2021
- CPT codes for Therapeutic Nuclear Medicine Procedures
- Estimated prevalence cases of cancer by country
- Clinical Trials on Therapeutic Nuclear Medicine (1/5)
- Clinical Trials on Therapeutic Nuclear Medicine (2/5)
- Clinical Trials on Therapeutic Nuclear Medicine (3/5)
- Clinical Trials on Therapeutic Nuclear Medicine (4/5)
- Clinical Trials on Therapeutic Nuclear Medicine (1/5)
- North America Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Country
- North America Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Radionuclide Type
- North America Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
- North America Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By End User
- Latin America Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Country
- Latin America Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Radionuclide Type
- Latin America Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
- Latin America Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By End User
- Western Europe Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Country
- Western Europe Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Radionuclide Type
- Western Europe Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
- Western Europe Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By End User
- Eastern Europe Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Country
- Eastern Europe Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Radionuclide Type
- Eastern Europe Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
- Eastern Europe Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By End User
- APECJ Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Country
- APECJ Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Radionuclide Type
- APECJ Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
- APECJ Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By End User
- China Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Radionuclide Type
- China Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
- China Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By End User
- Japan Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Radionuclide Type
- Japan Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
- Japan Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By End User
- MEA Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Country
- MEA Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Radionuclide Type
- MEA Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By Indication
- MEA Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2022–2028, By End User
- Global Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Region
- Global Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Radionuclide Type
- Global Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Indication
- Global Therapeutic Nuclear Medicines Market Value (US$ Mn) Analysis- and Opportunity Assessment 2013–2028, By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to Analyst- Global Radiopharmaceuticals Market Overview
- North America Therapeutic Nuclear Medicines Market Value Share By Country (2022 E)
- North America Therapeutic Nuclear Medicines Market Value Share By Radionuclide Type (2022 E)
- North America Therapeutic Nuclear Medicines Market Value Share Indication (2022 E)
- North America Therapeutic Nuclear Medicines Market Value Share By End User (2022 E)
- North America Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- North America Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- U.S. Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- U.S. Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- Canada Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- Canada Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- North America Therapeutic Nuclear Medicines Market Attractiveness Analysis by Radionuclide Type, 2022-2028
- North America Therapeutic Nuclear Medicines Market Attractiveness Analysis by Indication, 2022-2028
- North America Therapeutic Nuclear Medicines Market Attractiveness Analysis by End User, 2022-2028
- North America Therapeutic Nuclear Medicines Market Attractiveness Analysis by Country, 2022-2028
- Latin America Therapeutic Nuclear Medicines Market Value Share By Country (2022 E)
- Latin America Therapeutic Nuclear Medicines Market Value Share By Radionuclide Type (2022 E)
- Latin America Therapeutic Nuclear Medicines Market Value Share Indication (2022 E)
- Latin America Therapeutic Nuclear Medicines Market Value Share By End User (2022 E)
- Latin America Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- Latin America Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- Brazil Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- Brazil Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- Mexico Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- Mexico Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- Argentina Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- Argentina Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- Rest of Latin America Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- Rest of Latin America Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- Latin America Therapeutic Nuclear Medicines Market Attractiveness Analysis by Radionuclide Type, 2022-2028
- Latin America Therapeutic Nuclear Medicines Market Attractiveness Analysis by Indication, 2022-2028
- Latin America Therapeutic Nuclear Medicines Market Attractiveness Analysis by End User, 2022-2028
- Latin America Therapeutic Nuclear Medicines Market Attractiveness Analysis by Country, 2022-2028
- Western Europe Therapeutic Nuclear Medicines Market Value Share By Country (2022 E)
- Western Europe Therapeutic Nuclear Medicines Market Value Share By Radionuclide Type (2022 E)
- Western Europe Therapeutic Nuclear Medicines Market Value Share Indication (2022 E)
- Western Europe Therapeutic Nuclear Medicines Market Value Share By End User (2022 E)
- Western Europe Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- Western Europe Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- U.K. Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- U.K. Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- Germany Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- Germany Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- France Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- France Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- Italy Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- Italy Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- Spain Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- Spain Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- Rest of Western Europe Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- Rest of Western Europe Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- Western Europe Therapeutic Nuclear Medicines Market Attractiveness Analysis by Radionuclide Type, 2022-2028
- Western Europe Therapeutic Nuclear Medicines Market Attractiveness Analysis by Indication, 2022-2028
- Western Europe Therapeutic Nuclear Medicines Market Attractiveness Analysis by End User, 2022-2028
- Western Europe Therapeutic Nuclear Medicines Market Attractiveness Analysis by Country, 2022-2028
- Eastern Europe Therapeutic Nuclear Medicines Market Value Share By Country (2022 E)
- North America Therapeutic Nuclear Medicines Market Value Share By Radionuclide Type (2022 E)
- Eastern Europe Therapeutic Nuclear Medicines Market Value Share Indication (2022 E)
- Eastern Europe Therapeutic Nuclear Medicines Market Value Share By End User (2022 E)
- Eastern Europe Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- Eastern Europe Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- Russia Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- Russia Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- Poland Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- Poland Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- Rest of Eastern Europe Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- Rest of Eastern Europe Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- Eastern Europe Therapeutic Nuclear Medicines Market Attractiveness Analysis by Radionuclide Type, 2022-2028
- Eastern Europe Therapeutic Nuclear Medicines Market Attractiveness Analysis by Indication, 2022-2028
- Eastern Europe Therapeutic Nuclear Medicines Market Attractiveness Analysis by End User, 2022-2028
- Eastern Europe Therapeutic Nuclear Medicines Market Attractiveness Analysis by Country, 2022-2028
- APECJ Therapeutic Nuclear Medicines Market Value Share By Country (2022 E)
- APECJ Therapeutic Nuclear Medicines Market Value Share By Radionuclide Type (2022 E)
- APECJ Therapeutic Nuclear Medicines Market Value Share Indication (2022 E)
- APECJ Therapeutic Nuclear Medicines Market Value Share By End User (2022 E)
- APECJ Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- APECJ Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- India Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- India Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- Australia & NZ Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- Australia & NZ Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- ASEAN Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- ASEAN Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- Rest of APECJ Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- Rest of APECJ Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- APECJ Therapeutic Nuclear Medicines Market Attractiveness Analysis by Radionuclide Type, 2022-2028
- APECJ Therapeutic Nuclear Medicines Market Attractiveness Analysis by Indication, 2022-2028
- APECJ Therapeutic Nuclear Medicines Market Attractiveness Analysis by End User, 2022-2028
- APECJ Therapeutic Nuclear Medicines Market Attractiveness Analysis by Country, 2022-2028
- China Therapeutic Nuclear Medicines Market Value Share Indication (2022 E)
- China Therapeutic Nuclear Medicines Market Value Share By End User (2022 E)
- China Therapeutic Nuclear Medicines Market Value Share By End User (2022 E)
- China Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- China Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- China Therapeutic Nuclear Medicines Market Attractiveness Analysis by Radionuclide Type, 2022-2028
- China Therapeutic Nuclear Medicines Market Attractiveness Analysis by Indication, 2022-2028
- China Therapeutic Nuclear Medicines Market Attractiveness Analysis by End User, 2022-2028
- Japan Therapeutic Nuclear Medicines Market Value Share Indication (2022 E)
- Japan Therapeutic Nuclear Medicines Market Value Share By End User (2022 E)
- Japan Therapeutic Nuclear Medicines Market Value Share By End User (2022 E)
- Japan Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- Japan Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- Japan Therapeutic Nuclear Medicines Market Attractiveness Analysis by Radionuclide Type, 2022-2028
- Japan Therapeutic Nuclear Medicines Market Attractiveness Analysis by Indication, 2022-2028
- Japan Therapeutic Nuclear Medicines Market Attractiveness Analysis by End User, 2022-2028
- MEA Therapeutic Nuclear Medicines Market Value Share By Country (2022 E)
- MEA Therapeutic Nuclear Medicines Market Value Share By Radionuclide Type (2022 E)
- MEA Therapeutic Nuclear Medicines Market Value Share Indication (2022 E)
- MEA Therapeutic Nuclear Medicines Market Value Share By End User (2022 E)
- MEA Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- MEA Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- South Africa Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- South Africa Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- GCC Countries Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- GCC Countries Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- Rest of MEA Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- Rest of MEA Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- MEA Therapeutic Nuclear Medicines Market Attractiveness Analysis by Radionuclide Type, 2022-2028
- MEA Therapeutic Nuclear Medicines Market Attractiveness Analysis by Indication, 2022-2028
- MEA Therapeutic Nuclear Medicines Market Attractiveness Analysis by End User, 2022-2028
- MEA Therapeutic Nuclear Medicines Market Attractiveness Analysis by Country, 2022-2028
- Global Therapeutic Nuclear Medicines Market: Company Share Analysis (2021)
- Global Therapeutic Nuclear Medicines Market Share Analysis (%), By Region, 2022 & 2028
- Global Therapeutic Nuclear Medicines Market Y-o-Y Analysis (%), By Region, 2022-2028
- Global Therapeutic Nuclear Medicines Market Attractiveness Analysis by Region, 2022-2028
- Global Therapeutic Nuclear Medicines Market Share Analysis (%), By Radionuclide Type, 2022 & 2028
- Global Therapeutic Nuclear Medicines Market Y-o-Y Analysis (%), By Radionuclide Type, 2022-2028
- Global Therapeutic Nuclear Medicines Market Attractiveness Analysis by Radionuclide Type, 2022-2028
- Global Therapeutic Nuclear Medicines Market Share Analysis (%), By Indication, 2022 & 2028
- Global Therapeutic Nuclear Medicines Market Y-o-Y Analysis (%), By Indication, 2022-2028
- Global Therapeutic Nuclear Medicines Market Attractiveness Analysis by Indication, 2022-2028
- Global Therapeutic Nuclear Medicines Market Share Analysis (%), By End User, 2022 & 2028
- Global Therapeutic Nuclear Medicines Market Y-o-Y Analysis (%), By End User, 2022-2028
- Global Therapeutic Nuclear Medicines Market Attractiveness Analysis by End User, 2022-2028
- Global Therapeutic Nuclear Medicines Market Value Analysis (US$ Mn), 2013-2021
- Global Therapeutic Nuclear Medicines Market Value Forecast (US$ Mn), 2022-2028
- Global Therapeutic Nuclear Medicines Market Absolute $ Opportunity, 2022 - 2028
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
